Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DMEPOS codes reviewed

This article was originally published in The Gray Sheet

Executive Summary

CMS has made preliminary decisions regarding 112 requests for changes to HCPCS codes for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) in 2007. The agency will hear public comments on the decisions in a series of meetings from April 25 to May 5. During a Program Advisory & Oversight Committee meeting in September, DMEPOS stakeholders stressed the need to update and expand HCPCS codes for their products before competitive bidding is instituted in 2007. Without the update, suppliers under the system may hamper beneficiary access by providing the lowest quality products within each code, they warned (1"The Gray Sheet" Oct. 3, 2005, p. 15)...

You may also be interested in...



Diabetes Products Should Be Exempt From Competitive Bidding – Panel

Supplier and manufacturer stakeholders are urging CMS to exclude blood glucose testing products from the impending DMEPOS competitive bidding program

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel